NLARx Newsletter Header
NLARx News
October 9, 2008
In This Issue
In the States
Outrage of the Week
Prices & Access
Advertising & Marketing
Fraud & Abuse
Conflicts
Safety
Pharma Watch
Reimportation
Medicare
Medicaid
E-Records
Patents & Generics
Research Tips
Quick Links
Join Our Mailing List
In the States
MASSACHUSETTS: State Gets $10.6 Billion for Healthcare Insurance More
FLORIDA: Vioxx Settlement Doesn't Shield Merck from State Lawsuits More
Florida Sues Merck Over $80 Million in Vioxx Costs More
CALIFORNIA: Schwarzenegger Signs Bills Creating Hospital Privacy Oversight Office More
MAINE: Funds to improve drug safety awarded to 14 small hospitals More
LOUISIANA: Gov. Jindal's Administration To Work With Bush Administration on Medicaid Overhaul More
Outrages of the Week
Financial Rescue Bill Contains Gift For Drugmakers More
Suit Alleges Pfizer Spun Unfavorable Studies More
Prices and Access to Healthcare
Million-Dollar Medicines More
Employer-Based Premiums for Family Health Coverage Rise by 5% to $12,680 in 2008 More
Office of Personnel Management Estimates Premiums for Federal Employees Will Increase 8% in 2009 More
Report: Average Monthly Premium for Stand-Alone Medicare Prescription Drug Coverage to Increase 24% in 2009 to $37 More
Omens of Economic Ill: Medicaid Spending, Enrollment Turn Upward More
Getting Your Money's Worth in Health Care More
Roche Cuts Price Of Tarceva Cancer Med In UK More
AIDS Group Protests Roche Pricing In S. Korea More
Statehealthfacts.org adds New, Updated Information on Health Coverage and the Uninsured More

Advertising and Marketing
FDA Will Rewrite Rules For Marketing for Children More
Free Drug Samples in the United States: Characteristics of Pediatric Recipients and Safety Concerns More
Vyvanse Warning Letter: Too Late! More
Study: Drug Samples May Endanger Children More 
Public Health Benefit of TV Drug Ads Unclear More
EU Plan Gives Pharma Direct Access To Patients More
Cephalon to Pay $6.85 Million to Settle Case More
Congressman: DTC Tax Break May Get Axed More
FDA Warns Five Drugmakers Over ADHD Ads More
Pharma Spending On Unbranded Ads Is Falling More
As Predicted, Pharma Samples Are Under Attack More
Free drug samples may not be a great deal More
Pharma Dollars (Pounds, Euros) are Grassroots Seeds More
Fraud and Abuse
Medicare Expands Its Crackdown on Fraud More
Cephalon Pays $425 Million For Medicaid Fraud More
Lilly To Pay $62M To States Over Zyprexa Suits More
Peter Rost Wins A Big Round Against Pfizer More
Texas Settles Case Against Abbott Labs for $28M More
Walgreen Agrees To Pay $9.9M to DOJ, Four States To Settle Medicaid Billing Allegations More
Medicare Drops 10 Miami Health Agencies, Citing Fraud More
Abbott Laboratories Settles with Pennsylvania AG for $6.95 Million More
Boehringer Ingelheim Roxane Settles Price Inflation Case More
Cardinal Pays $34M For Violating Substances Act More

Conflicts of Interest
JAMA Study on News Media Coverage of Medication Research More
Media Often Fail to Report Pharma Funding More
Top Psychiatrist Failed to Report Drug Income More Editorials Address Drug Companies' Announcements To Disclose Some Physician Payments More
DOT Ties to Sleep Aid Industry Riles Truckers  More
University of Minnesota Task Force Seeks Greater Transparency in Faculty Conflicts of Interest With Pharmaceutical Companies More
Pharma-Connected DTC Ad Group Strips Website of Info More
Oh Dear Me More
Multiple Investigations of FDA PR Contract More
AstraZeneca Paid Iressa Guideline Docs In Japan More

Safety and Clinical Trials
Senate Approves Bill Intended To Stop Operation of Online Rogue Pharmacies More
Drug Makers to Curb Cold-Medicine Sales More

FDA: Deaths Higher for Stroke Patients on Johnson & Johnson's Eprex More
Wyeth Asks Supreme Ct to Support Preemption More
Searching for Clarity: A Primer on Medical Studies More
FDA Reviewing Epogen and Procrit Side Effects After Study Identifies Risk of Death More
Merck Ends Development of Obesity Drug Taranabant More
Pharma Watch
Pfizer's New Focus Will Usher in a Golden Age of Pharma Social Media Marketing More
Lilly Agrees to Acquire ImClone for $6.5 Billion More
Beyond ImClone: Carl Icahn Loads Up On Biotech More
Trade and Reimportation
NAFTA's Investment Provisions Pose Questions for Health Policy in Canada, States More
Company: Canadian Law Hinders Ship- ments of Generic Antiretrovirals to Developing Countries More
Union Considers Canadian Provider More
Boston Ending Canadian Drug Importation Program After Few City Workers Enroll More
China Is Pharma's No. 1 Outsourcing Destination More

Medicare 
Senate Passes Bill To Aid Low-Income Seniors Pay Medicare Premiums More
Medicare Won't Pay for Medical Errors More
Senate Finance Committee Leaders Raise Concerns About Problems in Medicare Appeals Office More
Study: Nearly Two-Thirds of Prescriptions Initially Filled by Medicare Clients Were for Branded Drugs More
Medicaid
Medicaid Rolls, Spending Up in Bleak Economy More

States See Higher Medicaid Enrollment as Economic Downturn Persists, Study Finds More
GAO Estimates 6.5 Million Child Medicaid Beneficiaries Have Untreated Tooth Decay More
Kaiser Daily Health Policy Report Highlights Medicaid Developments in Three States More

Electronic Records
Health Care IT Trade Group Expresses Opposition to Rep. Stark's Electronic Health Records Bill More
Patents and Generics
Research: State Legislation Restricting Generics Would Increase Costs $29B Over 10 Years More
Drug Samples Can Mean Fewer Generic Prescriptions for the Uninsured More
Former President Bill Clinton Publicly Expresses Support for Global Access Licensing by Universities  More

Research Tips
New Reports from Families USA Online More